tirzepatide parkinson Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah Amersi, MD: OB-GYNs Dual GLP-1 and GIP Agonist

Planning for chronic use rather than temporary intervention prevents disappointment and allows realistic budgeting for ongoing costs

We do not want this to happen because cell damage can lead to many health conditions, serious disease and cancer

Its not just about the scale its about energy, confidence, and feeling good again

Certain individuals should avoid tirzepatide use, including those with a history of pancreatitis, medullary thyroid cancer, or severe gastrointestinal issues

The key agents you will see discussed throughout this post include: Semaglutide (Ozempic/Wegovy/Rybelsus): Weekly subcutaneous or once-daily oral